Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page components related to study documents and metadata (including the SAP note and several document entries) have been removed, reducing the amount of visible procedural and documentation information on the study record.SummaryDifference18%

- Check26 days agoChange DetectedThe revision history now shows version 3.7.0 in place of 3.6.6, reflecting a new page update.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows revision v3.6.6, replacing v3.6.5. This update reflects a new site revision for the page, with no changes to study details or outcomes.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now indicates a new revision tag: v3.6.5, and the previous v3.6.4 tag has been removed. This reflects a routine platform update without changes to the study content or how users interact with the page.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a site version update and does not change the study content.SummaryDifference0.1%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.